Skip to main content

PROVINCIAL DRUG COVERAGE – Nova Scotia

AS OF March 2026

Coverage is under constant review and is subject to change.

Access to a generic or biosimilar equivalent is generally reported to be identical to that of the relevant brand name medication.

TYPE OF LISTING

NOVA SCOTIA COVERAGE

Bisphosphonates

Etidronate

Didronel; Generics Available

Not in Drug Formulary

Alendronate

Fosamax; Generics Available

Regular Benefit (10mg, 70mg); Non-Benefit (5mg)

Fosavance; Generics Available

Regular Benefit (70 mg/5600 IU); Non-Benefit (70 mg/2800 IU)

Risedronate

Actonel; Generics Available

Regular Benefit (5 mg Generics, 30mg Generics, All 35mg); Non-Benefit (All 150mg); Actonel 5mg & 30mg Discontinued

Actonel; DR

Non-Benefit

Zoledronic Acid

Aclasta; Generics Available

Regular Benefit (5mg inj); Non-Benefit (4mg inj)

SERMs

Raloxifene

Evista; Generics Available

Regular Benefit

Teriparatide (PTH)

Forteo; Generics Available

Non-Benefit

Osnuvo (biosimilar)

Non-Benefit

Denosumab

Prolia

Limited Coverage

Jubbonti (biosimilar)

Limited Coverage

Stoboclo (biosimilar)

Limited Coverage

Osenvelt (biosimilar)

Limited Coverage

Romosozumab

Evenity

Limited Coverage

Click to view further information on available coverage in Nova Scotia:

Nova Scotia Drug Formulary List

© Osteoporosis Canada, 2026
Charitable Registration No. 89551 0931 RR 0001